Related Experiment Video

Updated: May 10, 2026

Lateral Chronic Cranial Window Preparation Enables In Vivo Observation Following Distal Middle Cerebral Artery Occlusion in Mice
08:41

Lateral Chronic Cranial Window Preparation Enables In Vivo Observation Following Distal Middle Cerebral Artery Occlusion in Mice

Published on: December 29, 2016

[Therapeutic correction of mild cognitive impairment in patients with chronic cerebral ischemia]

M M Odinak, A V Kashin, A Iu Ememlin

    Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
    |June 7, 2013
    PubMed

    Insights

    This study investigated Vitrum Memory for mild vascular cognitive impairment in elderly patients. The 12-week therapy significantly improved neurodynamic and regulatory functions in individuals with dyscirculatory encephalopathy.

    Area of Science:

    • Gerontology
    • Neurology
    • Pharmacology

    Background:

    • Elderly cognitive impairment is primarily caused by neurodegenerative and cerebrovascular diseases.
    • Vascular cognitive impairment (VCI) is a complex condition with diverse pathologies and clinical presentations, extending beyond dementia.
    • Current understanding necessitates updated classification principles and therapeutic strategies for VCI.

    Purpose of the Study:

    • To review new classification principles for vascular cognitive impairment.
    • To explore potential therapeutic corrections for VCI.
    • To evaluate the efficacy and safety of Vitrum Memory in patients with mild VCI.

    Main Methods:

    • Conducted a 12-week open-label, randomized therapeutic study with a control group.
    • Included patients diagnosed with mild vascular cognitive impairment and stages I-II dyscirculatory encephalopathy.
    • Assessed the impact of Vitrum Memory on neurodynamic and regulatory functions.

    Main Results:

    • Vitrum Memory therapy demonstrated significant improvements in neurodynamic functions.
    • Regulatory functions of patients also showed significant enhancement following the 12-week treatment.
    • The study confirmed the safety profile of Vitrum Memory in the studied population.

    Conclusions:

    • Vitrum Memory is a potentially effective therapeutic option for mild vascular cognitive impairment.
    • The findings support the use of Vitrum Memory for patients with early-stage dyscirculatory encephalopathy.
    • Further research into VCI classification and treatment is warranted.

    Related Concept Videos

    Ischemic Stroke l: Introduction01:15

    Ischemic Stroke l: Introduction

    Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
    Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

    Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

    Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
    Ischemic Stroke ll: Pathophysiology01:15

    Ischemic Stroke ll: Pathophysiology

    An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
    Transient Ischemic Attack l: Introduction01:26

    Transient Ischemic Attack l: Introduction

    A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
    Alzheimer's Disease: Treatment01:22

    Alzheimer's Disease: Treatment

    Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...